News Daily News FDA Approves Triple Therapy Polypill for High Blood Pressure Michael O'Riordan June 10, 2025
News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025
News Daily News Use of Secondary CVD Prevention Meds Still Meager Worldwide Caitlin E. Cox February 03, 2025
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Daily News Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions L.A. McKeown December 17, 2021
News Daily News Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD Todd Neale January 19, 2017
News Daily News Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly Michael O'Riordan July 21, 2016
News Daily News La Infrautilización del Tratamiento Médico se asocia a Más Episodios Adversos en Pacientes Muy Ancianos Michael O'Riordan July 21, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Daily News Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI Yael L. Maxwell December 13, 2012
News Daily News Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients Yael L. Maxwell December 13, 2012